Holloway; M. Katharine
Patent Applications and Registrations
Patent applications and USPTO patent grants for Holloway; M. Katharine.The latest application filed is for "hiv protease inhibitors".
- Holloway; M. Katharine - Lansdale PA
- HOLLOWAY; M. Katharine - West Point PA US
| Patent | Date |
|---|---|
| Piperazine derivatives as HIV protease inhibitors Grant 10,138,255 - Williams , et al. Nov | 2018-11-27 |
| HIV protease inhibitors Grant 9,994,587 - McCauley , et al. June 12, 2 | 2018-06-12 |
| Piperazine derivatives as HIV protease inhibitors Grant 9,840,478 - Williams , et al. December 12, 2 | 2017-12-12 |
| Hiv Protease Inhibitors App 20170217986 - McCauley; John A. ; et al. | 2017-08-03 |
| Piperazine Derivatives As Hiv Protease Inhibitors App 20170073354 - Williams; Peter D. ; et al. | 2017-03-16 |
| Piperazine Derivatives As Hiv Protease Inhibitors App 20160159752 - Williams; Peter D. ; et al. | 2016-06-09 |
| HCV NS3 Protease Inhibitors App 20150266897 - Liverton; Nigel J. ; et al. | 2015-09-24 |
| HIV protease inhibitors Grant 8,497,383 - Coburn , et al. July 30, 2 | 2013-07-30 |
| Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease Grant 8,399,473 - Nantermet , et al. March 19, 2 | 2013-03-19 |
| HCV NS3 protease inhibitors Grant 8,278,322 - Holloway , et al. October 2, 2 | 2012-10-02 |
| HCV NS3 protease inhibitors Grant 8,216,999 - Holloway , et al. July 10, 2 | 2012-07-10 |
| Hiv Protease Inhibitors App 20120142752 - Coburn; Craig A. ; et al. | 2012-06-07 |
| 2-aminopyridine compounds useful as .beta.-secretase inhibitors for the treatment of alzheimer's disease Grant 7,932,275 - Coburn , et al. April 26, 2 | 2011-04-26 |
| HCV NS3 Protease Inhibitors App 20110028494 - Holloway; M. Katharine ; et al. | 2011-02-03 |
| HCV NS3 protease inhibitors Grant 7,879,797 - Holloway , et al. February 1, 2 | 2011-02-01 |
| HCV NS3 Protease Inhibitors App 20100099695 - Liverton; Nigel J. ; et al. | 2010-04-22 |
| Macrocyclic Spiropiperidine Beta-secretase Inhibitors For The Treatment Of Alzheimer's Disease App 20100029701 - Nantermet; Philippe G. ; et al. | 2010-02-04 |
| Hcv Ns3 Protease Inhibitors App 20090124661 - HOLLOWAY; M. Katharine ; et al. | 2009-05-14 |
| HCV NS3 protease inhibitors App 20090075869 - Holloway; M. Katharine ; et al. | 2009-03-19 |
| HCV NS3 protease inhibitors Grant 7,470,664 - Holloway , et al. December 30, 2 | 2008-12-30 |
| 2-Aminopyridine Compounds Useful as Beta-Secretase Inhibitors For the Treatment of Alzheimer's Disease App 20080161363 - Coburn; Craig A. ; et al. | 2008-07-03 |
| 2-Aminothiazole Compounds Useful As Aspartyl Protease Inhibitors App 20070203147 - Coburn; Craig A. ; et al. | 2007-08-30 |
| HCV NS3 protease inhibitors App 20070027071 - Holloway; M. Katharine ; et al. | 2007-02-01 |
| HIV protease inhibitors useful for the treatment of AIDS Grant 5,717,097 - Vacca , et al. February 10, 1 | 1998-02-10 |
| HIV protease inhibitors useful for the treatment of AIDS Grant 5,413,999 - Vacca , et al. May 9, 1 | 1995-05-09 |
| NCAGE Code | 4X3U7 | HOLLOWAY, M KATHARINE |
| CAGE Code | 4X3U7 | HOLLOWAY, M KATHARINE |
| DUNS | 808225952 | HOLLOWAY, M KATHARINE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 